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The role of the By-subunits in the interaction of G-proteins was examined with /I,-adrenoceptors purified from turkey 
erythrocytes and pure By-subunits prepared from turkey erythrocytes and bovine brain. On a non-denaturing polyacryl- 
amide gel, the mobility of By-subunits was increased when incubated with /?,-adrenoceptor and the /?,-adrenergic agonist 
I-( -)-isoproterenol, whereas on incubation with the antagonist I-alprenolol the mobility was unchanged. Furthermore, 
the /I,-adrenoceptor was retarded on a Sephadex G-50 column equilibrated with By-subunits and agonist. No retardation 
occurred in the presence of antagonist. These data suggest a direct interaction of activated &-adrenoceptors with isolated 
j?y-subunits of G-proteins. 
&-Adrenoceptor; G-protein; By-subunit; Protein-protein interaction 
1. INTRODUCTION 
A family of GTP-binding proteins function as 
transducers in signal transfer from hormone recep- 
tors to adenylyl cyclase [l] and other targets [2]. 
These G-proteins are all heterotrimers with a- 
subunits of 39 to 45 kDa which bind GTP and are 
substrates for toxins, such as cholera toxin and/or 
pertussis toxin, and& and y-subunits which do not 
bind GTP. The B-subunits have molecular masses 
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of 35 or 36 kDa depending on the source of G- 
protsin [3,4], whereas the y-subunits are more 
heterogeneous with molecular masses ranging 
from 5 to 10 kDa [5]. Only recently, detailed 
studies were carried out with separate and pure 
components in reconstituted lipid vesicles to clarify 
the role of the fly-subunits in signal transmission 
from P-adrenoceptors to adenylyl cyclase [6-81. 
The results may be summarized as follows: the fly- 
subunits are obligatorily required for ADP- 
ribosylation of G,, Gi and G, which are all per- 
tussis toxin substrates [9]. The &subunits 
stimulate the Mg’+-dependent binding of GTPyS 
to G,, Gi and G,. Addition of a molar excess of 
fly-subunits promotes deactivation of (AIF&- 
activated G, [lo], but most significant is an 
attenuation of basal, e.g. GTP or GTPyS (non- 
hormonally) activated adenylyl cyclase by fly- 
subunits [6,11]. An anchor role was also ascribed 
to the y-subunit for insertion of G-proteins into 
the membrane [12] and recently reported evidence 
points to a role of &subunits in receptor G- 
coupling. For example, a moderate molar excess of 
&-subunits promotes receptor-activated GTPase 
activity in the case of P-adrenoceptor and G, [7] 
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and bleached rhodopsin and Gt, or Gb [ 13,141. 
Moreover, &subunits shift partially purified 
muscarinic acetylcholine receptor co-reconstituted 
with G, into lipid vesicles towards the high-affinity 
state for agonists [151. A putative direct interaction 
between &subunits and rhodopsin may be de- 
duced from the fact that a polyclonal antibody 
preparation against fly-transducin contains anti- 
idiotypic antibodies against rhodopsin, because 
this could be interpreted to mean that rhodopsin 
has a specific binding domain for&subunits [ 161. 
This interpretation is supported by the fact that 
transducinfly-subunits inhibit the phosphorylation 
of rhodopsin by rhodopsin kinase and interfere 
with binding of antibodies directed against 
carboxyl-terminal peptides containing the phos- 
phorylation sites in rhodopsin [ 171. To these data 
suggesting direct interaction between fly-subunits 
and receptors we now add information indicating 
that pure &subunits of G-proteins prepared from 
turkey erythrocytes and bovine brain interact with 
Pi-adrenoceptor also purified from turkey erythro- 
cytes when the receptor is activated by a hormone 
agonist. 
2. MATERIALS AND METHODS 
The Pi-adrenoceptors from turkey erythrocyte membranes 
were purified according to published procedures [18,19]. G, and 
Gb from turkey erythrocytes were purified as described by Nor- 
thup et al. [IO]. The&-subunits of G-proteins were purified to 
homogeneity either from bovine brain [20] or from turkey 
erythrocytes [lo]. The purified &-subunits were concentrated 
on a hydroxyapatite column and stored at -80°C in 25 mM 
Hepes buffer @H 8.0) containing 100 mM NaCl, 1 mM DTT, 
0.05% Lubrol-PX and 10% glycerol. The 81 AR and ,f3~- 
preparations were free of Giu, Cm and G, as shown by 
[‘sS]GTPyS binding, silver staining [21], [‘*P]ADP-ribo- 
sylation and immunoblotting techniques (see fig.1). [‘*PINAD 
was synthesized as described by Cassel and Pfeuffer [22]. Per- 
tussis toxin catalyzed ADP-ribosylation was carried out by the 
procedure of Bokoch et al. 1231. Immunoblotting was per- 
formed according to Towbin et al. [24] using polyclonal anti- 
bodies against G,-peptide (379-394) from bovine brain [25]. 
The concentrations of Bt-adrenoceptor and &subunits were 
measured by [3H]DHA binding and the [‘HJfluorodinitro- 
benzene method, respectively [19]. The binding of &-subunits 
to thefli-adrenoceptor was examined by gel permeation [26,27]. 
For that purpose, the fit-adrenoceptor was applied to a 
Sephadex G-50 column equilibrated with ‘**I+subunits (3ooO 
cpm/pmol) in 20 mM Hepes, 100 mM NaCl, 0.5 mM DTT and 
0.25% monolauroyl sucrose buffer (pH 8.0). The radioactivity 
of each fraction was counted. 
The similar molecular mass of j3rAR from turkey 
erythrocytes (40 and 50 kDa) and of &subunit complexes 
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(45 kDa) and comparable isoelectric points (pl) 5.8-6.2 [28,29] 
made it seem attractive to use native polyacrylamide gel in order 
to detect association between fliAR and &subunits in the 
presence of agonist. Non-denaturing polyacrylamide gels 
(4-5%) were prepared by the method of Hames [30] without a 
stacking gel. Gel electrophoresis was carried out under the con- 
ditions of Laemmli [31] except that SDS was omitted and 
replaced by 0.25% monolauroyl sucrose for the gel preparation 
and for the running buffer. Monolauroyl sucrose is a neutral 
detergent with a high cmc which does not denaturePAR and G- 
proteins and prevents aggregation of hydrophobic proteins [19]. 
Depending on experimental conditions the gels were prepared 
with or without ligands. The electrophoresis was carried out 
overnight at 4°C and 8 mA. /3tAR and &-subunits were la- 
belled with “‘1 by the chloramine-T method [32]. 
3. RESULTS AND DISCUSSION 
The data in fig.2 show an increased mobility of 
1251-labelled fly-subunits in 4% non-denaturing 
polyacrylamide gels as a function of increasing 
PAR concentrations. The mobility increase was 
only observed in the presence of 10e4 M l-( -)- 
isoproterenol in the preincubation and in the gel 
and in the running buffer. In the control (fig.2B) 
isoproterenol was replaced in the preincubation 
and in the gel by 10e6 M I-alprenolol. No change 
of &-subunit mobility was recorded. The same ex- 
periment was carried out using bovine brain fly- 
A. Protein 6, MP-ADP- C. lmmunoblot 
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Fig. 1. Purity of the components. (A) Silver stain of &-subunits 
from bovine brain (1) and ,&AR from turkey erythrocytes (2) 
after SDS-PAGE. (B) Autoradiogram of Gk ADP-ribosylated 
by pertussis toxin. 10 ng Gk (3) from turkey erythrocytes in the 
presence of 20 ng &subunits, 300 ng fly-subunits (4) and 
300 ng fiiAR (5) in the presence of 20 ng .&-subunits. (C) 
Immunoblots of 12.5 ng rabbit liver G, (6), 2.5 ng G, (7). 
875 ng ,+subunits (8) and 300 ng /3iAR (9). Blots were 
processed with rabbit anti-G,-peptide serum (1: 750) and with 
peroxidase-labelled goat antibodies to rabbit IgG. &Subunits 
from turkey erythrocytes were likewise free from G, and Gb 
as estimated by the same techniques (not shown). 
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Fig.2. Interactions in non-denaturing polyacrylamide gels 
betweenj3rAR and&subunits of G-proteins in the presence of 
agonist or antagonist. The gels (4010) containing 0.25% 
monolauroyl sucrose were prepared without stacking gel in the 
presence of 10e4 M 1-( - )-isoproterenol or 10m6 M I-alprenolol. 
The running buffer contained 0.1% monolauroyl sucrose and 
the same concentration of ligands. The samples in A and B 
containedPiAR and&-subunits with 1500 cpm of ‘251-labelled 
&subunits from turkey erythrocytes and in A 10e4 M 
isoproterenol and in B 10e6 M alprenolol in 20 mM Hepes, 
0.3 mM DTT, 100 mM NaCl buffer @H 7.5). The detergent 
concentrations of digitonin, Lubrol-PX and monolauroyl 
sucrose in the samples were 0.0970, 0.05% and 0.25010, 
respectively. The samples were preincubated at 30°C for 
30 min. Electrophoresis was carried out overnight at 4°C and 
8 mA. (A) Mobilities of fly-subunits (4 pmol) in the presence of 
agonist but no addition of ,8tAR (lane 1), with 2 pmol fliAR 
(lane 2), with 3 pmol @iAR (lane 3), with 4 pmol @iAR (lane 4) 
and with 5 pmol,9iAR (lane 5). (B) Mobilities of @subunits 
(5 pmol) in the presence of antagonist but no addition of fliAR 
(lane I), with 2 pmolfiiAR (lane 2), with 4 pmolj3rAR (lane 3), 
with 6 pmol PiAR (lane 4) and with 8 pmol j3iAR (lane 5). 
subunits (see fig.4A). The results were like those 
obtained with the &subunits from avian 
erythrocytes. The converse experiments were also 
carried out using 1251-flAR and increasing concen- 
trations of fly-subunits. Similar results like those 
shown in fig.2A were obtained. The mobility of 
p&R in the presence of &subunits was faster 
6- 
5 10 15 20 
Fraction number 
Elution profiles of purified Pi-adrenoceptor from a 
Sephadex G-50 column equilibrated with ‘251-labelled &- 
subunits. A Sephadex G-50 column (0.4 x 8.0 cm) was 
equilibrated with 20 mM Hepes, 100 mM NaCl, 0.5 mM DTT 
and 0.25% monolauroyl sucrose buffer (pH 8.0) which 
contained 30 nM ‘251-fl~-subunits (3000 cpm/pmol) from 
bovine brain with lOA M 1-( - )-isoproterenol (M), or with 
low6 M 1-alprenolol (a-) and without ligands (X-X). The 
column equilibration was carried out at room temperature. The 
Pi-adrenoceptor (2 pmol) from turkey erythrocytes was 
preincubated with or without ligand for 15 min at room 
temperature and then applied to the column (flow rate = 
70 fll/min). Each fraction (100,ul) was counted for 
radioactivity. The data are representative for three identically 
performed experiments. 
than in their absence. Again the mobility increase 
was only seen in the presence of isoproterenol (not 
shown). Binding of fly-subunits to PiAR was also 
followed by equilibrium binding on a gel-filtration 
column (fig.3). A peak of iz51-radioactivity cor- 
responding to a &receptor complex was observed 
in the presence of isoproterenol. Assuming a 1: 1 
complex of fly and ,&tAR, the radioactive peak is 
consistent with 1.78 pmol of 2 pmolPiAR applied. 
On the other hand, the antagonist prevented the in- 
teraction of ,6iAR with fly-subunits like in the 
above experiments. But a smaller peak of 1251-fiy- 
subunits was observed even in the absence of 
ligand indicating an interaction between non- 
liganded PAR and fly. A similar, but considerably 
smaller trough centered at fraction 15 in the 
presence of alprenolol results from the fact that the 
receptor was applied to the column in the absence 
of fly-subunits. In order to explain the clear 
separation of the fly-adrenoceptor complex, addi- 
tional absorptive forces exerted bv the Sephadex 
227 
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matrix must be postulated. It was noted that 
among the conditions for preincubation, 
temperature was crucial: when the temperature for 
the preincubation was lowered from 30°C to 4°C 
the mobility change in the presence of agonist was 
not observed (cf. fig.4A and B). 
A considerable effort was made to detect a 
change in the affinity of the ,&lAR on co- 
reconstitution with &-subunits into lipid vesicles 
using methods established in this laboratory [7,18]. 
However, the reconstituted turkey PrAR did not 
respond well to interaction with either non- 
activated or activated forms of G, with a shift from 
a high-affinity to low-affinity state in the presence 
A 8 
123 123 
Fig.4. Influence of temperature on the mobility of&-subunits. 
The non-denaturing el (5%) containing 0.25% monolauroyl 
sucrose was prepared without ligand, but the running buffer 
contained 10e4 M 1-( -)-isoproterenol and 0.3 mM DTT. The 
samples contained turkey erythrocyte ,&AR and fly-subunits 
from bovine brain and low4 M isoprorerenol in 20 mM Hepes, 
100 mM NaCl buffer (pH 7.5). The detergent concentrations in 
the samples were 0.05% digitonin, 0.05% Lubrol-PX and 
0.25% monolauroyl sucrose. In A the reaction mixtures were 
incubated for 30 min at 30°C and in B for 1 h in an ice bath. 
Electrophoresis was carried out in both cases overnight at 4°C. 
(A) Mobilities of & (3 pmol) after incubation at 30°C in the 
presence of agonist but without PiAR (lane l), with 2 pmol 
,&iAR (lane 2) and with 4 pmol ,&iAR (lane 3). (B) As in A, but 
after incubation in an ice bath. 
of the hormone agonist. But, one should 
remember that in turkey membranes the sensitivity 
of this shift is controversial [33-351. This un- 
favorable property of the turkey PrAR might have 
been responsible for the failure to obtain une- 
quivocal effects with co-reconstituted &subunits 
on ligand displacement at the receptor. 
The experiments reported here show that 
purified turkey,&rAR can interact with&subunits 
of G-proteins from the same source or from bovine 
brain. The consequence of this interaction prob- 
ably is formation of a ‘hormone-PiAR @y- 
complex’. The molecular basis of the conforma- 
tional changes responsible for the PAR-fly interac- 
tion is not known. The mobility change of the in- 
teracting proteins suggests a decreased pK, but for 
what discrete structural change, protonation- 
deprotonation might be indicative is as obscure as 
is a possible functional significance for interac- 
tions of fl-adrenoceptors with fly-subunits in the 
course of signal transmission in the native 
membrane. 
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